Tamara P. Miller

1.0k total citations
70 papers, 488 citations indexed

About

Tamara P. Miller is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Tamara P. Miller has authored 70 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Public Health, Environmental and Occupational Health, 36 papers in Pediatrics, Perinatology and Child Health and 27 papers in Oncology. Recurrent topics in Tamara P. Miller's work include Childhood Cancer Survivors' Quality of Life (31 papers), Acute Lymphoblastic Leukemia research (30 papers) and Neutropenia and Cancer Infections (23 papers). Tamara P. Miller is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (31 papers), Acute Lymphoblastic Leukemia research (30 papers) and Neutropenia and Cancer Infections (23 papers). Tamara P. Miller collaborates with scholars based in United States, Canada and Australia. Tamara P. Miller's co-authors include Richard Aplenc, Brian T. Fisher, Alix E. Seif, Kelly Getz, Rochelle Bagatell, Yimei Li, Yuan‐Shung Huang, Mala Murthy, Thomas L. Schwarz and Peter C. Adamson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Tamara P. Miller

62 papers receiving 484 citations

Peers

Tamara P. Miller
Osvaldo Marrero United States
C. Lüke Australia
Wan‐Ju Lee United States
Caterina Mele Italy
G. Roussey France
Maria Lourdes Gonzalez Suarez United States
Elisabeth Couto Norway
Vineet Kumar Kamal India
Pamela Clax United States
W. Dunlop United Kingdom
Osvaldo Marrero United States
Tamara P. Miller
Citations per year, relative to Tamara P. Miller Tamara P. Miller (= 1×) peers Osvaldo Marrero

Countries citing papers authored by Tamara P. Miller

Since Specialization
Citations

This map shows the geographic impact of Tamara P. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara P. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara P. Miller more than expected).

Fields of papers citing papers by Tamara P. Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara P. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara P. Miller. The network helps show where Tamara P. Miller may publish in the future.

Co-authorship network of co-authors of Tamara P. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Tamara P. Miller. A scholar is included among the top collaborators of Tamara P. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamara P. Miller. Tamara P. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miller, Tamara P., Ethan A. Poweleit, Austin L. Brown, et al.. (2025). What Is the Expected Clearance of Methotrexate? A Therapeutic Drug Monitoring Reference Guide for High‐Dose Methotrexate Use in Pediatric Malignancies. Pediatric Blood & Cancer. 72(7). e31744–e31744. 1 indexed citations
2.
Li, Amanda M., Catherine Aftandilian, Susan I. Colace, et al.. (2024). A Retrospective Study of Inotuzumab Ozogamicin in Individuals with Down Syndrome and B-Cell Acute Lymphoblastic Leukemia. Blood. 144(Supplement 1). 4204–4204.
3.
Siegel, Robert D., Kristine B. LeFebvre, Sarah Temin, et al.. (2024). Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards. JCO Oncology Practice. 20(10). 1314–1330. 4 indexed citations
4.
Fisher, Brian T., Jesse Blumenstock, Craig L K Boge, et al.. (2024). Approach for defining human adenovirus infection and disease for central review adjudication in clinical studies. Pediatric Transplantation. 28(3). e14750–e14750. 1 indexed citations
5.
6.
DeGroote, Nicholas P., Holly Lindsay, Eric S. Schafer, et al.. (2024). Toxicity profile of high‐dose methotrexate in young children with central nervous system tumors. Pediatric Blood & Cancer. 71(10). e31213–e31213.
7.
Miller, Tamara P., Kelly Getz, M. Monica Gramatges, et al.. (2024). Automated Electronic Health Record Data Extraction and Curation Using ExtractEHR. JCO Clinical Cancer Informatics. 8(8). e2400100–e2400100. 1 indexed citations
8.
White, Brandon, et al.. (2024). An Interpretable Machine Learning Framework for Rare Disease: A Case Study to Stratify Infection Risk in Pediatric Leukemia. Journal of Clinical Medicine. 13(6). 1788–1788. 7 indexed citations
9.
Summers, Ryan J., et al.. (2023). High burden of clinically significant adverse events associated with contemporary therapy for pediatric T‐cell acute lymphoblastic leukemia/lymphoma. Pediatric Blood & Cancer. 70(11). e30571–e30571. 1 indexed citations
10.
Li, Yimei, Kelly Getz, Mark Ramos, et al.. (2023). Acute and chronic kidney injury during therapy for pediatric acute leukemia: A report from the Leukemia Electronic Abstraction of Records Network (LEARN). Pediatric Blood & Cancer. 70(12). e30696–e30696. 2 indexed citations
11.
Freedman, Jason L., Natalie Bradford, Yin Ting Cheung, et al.. (2023). Supportive Care in Pediatric Oncology: Opportunities and Future Directions. Cancers. 15(23). 5549–5549. 9 indexed citations
12.
Elgarten, Caitlin W., John A. Kairalla, Joel Thompson, et al.. (2023). SARS‐CoV‐2 infections in patients enrolled on the Children's Oncology Group standard‐risk B‐cell acute lymphoblastic leukemia trial, AALL1731. SHILAP Revista de lepidopterología. 4(3). 745–750. 2 indexed citations
13.
DeGroote, Nicholas P., Thomas F. Cash, Sharon M. Castellino, et al.. (2022). Infectious events in pediatric patients with acute lymphoblastic leukemia/lymphoma undergoing evaluation for fever without severe neutropenia. Cancer. 128(23). 4129–4138. 1 indexed citations
14.
DeGroote, Nicholas P., Frank G. Keller, Katharine E. Brock, et al.. (2022). Characteristics and outcomes of pediatric oncology patients at risk for guardians declining transfusion of blood components. Cancer Reports. 6(1). e1665–e1665. 1 indexed citations
15.
McNeer, Jennifer L., Maureen M. O’Brien, Susan R. Rheingold, et al.. (2021). A Phase 3 Randomized Trial of Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL: Safety Phase Results from Children's Oncology Group Protocol AALL1732. Blood. 138(Supplement 1). 3398–3398. 8 indexed citations
16.
Li, Yimei, Kelly Getz, Caitlin W. Elgarten, et al.. (2020). Identifying relapses and stem cell transplants in pediatric acute lymphoblastic leukemia using administrative data: Capturing national outcomes irrespective of trial enrollment. Pediatric Blood & Cancer. 68(9). e28315–e28315. 1 indexed citations
17.
Miller, Tamara P., Brian T. Fisher, Kelly Getz, et al.. (2019). Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events. Pediatric Blood & Cancer. 66(7). e27747–e27747. 39 indexed citations
18.
Chambers, Tiffany M., Evanette Burrows, Tamara P. Miller, et al.. (2019). Delays in Therapy Do Not Impact Survival in Childhood Acute Lymphoblastic Leukemia: A Report from the Learn Consortium. Blood. 134(Supplement_1). 1304–1304. 2 indexed citations
19.
Mrakotsky, Christine, Lewis B. Silverman, Suzanne E. Dahlberg, et al.. (2011). Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age‐dependent: Report from Dana‐Farber Cancer Institute ALL Consortium Protocol 00‐01. Pediatric Blood & Cancer. 57(3). 492–498. 30 indexed citations
20.
Murthy, Mala, et al.. (2010). Sec5, a member of the exocyst complex, mediates Drosophila embryo cellularization. Development. 137(16). 2773–2783. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Osvaldo Marrero Breakdown of academic impact, for papers by C. Lüke Breakdown of academic impact, for papers by Wan‐Ju Lee Breakdown of academic impact, for papers by Caterina Mele Breakdown of academic impact, for papers by G. Roussey Breakdown of academic impact, for papers by Maria Lourdes Gonzalez Suarez Breakdown of academic impact, for papers by Elisabeth Couto Breakdown of academic impact, for papers by Vineet Kumar Kamal Breakdown of academic impact, for papers by Pamela Clax Breakdown of academic impact, for papers by W. Dunlop
Rankless by CCL
2026